[1]. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy With Midventricular Obstruction and Papillary Muscle Abnormalities.
JACC. Case reports [Volume]30 [Issue]8 [Page]103183 -103183 （2025/） [Reviewed] Yes
[DOI] [2]. Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM Study.
Circulation journal : official journal of the Japanese Circulation Society （2024/） [Reviewed] Yes
[3]. Consensus Statement on Renal Denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)
CIRCULATION JOURNAL [Volume]88 [Issue]10 [Page]1718 -1725 （2024/） [Reviewed] Yes
[DOI] [4]. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.
Cardiovascular intervention and therapeutics （2024/） [Reviewed] Yes
[5]. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)
HYPERTENSION RESEARCH （2024/） [Reviewed] Yes
[DOI]